{"id":339298,"date":"2026-11-04T15:00:18","date_gmt":"2026-11-04T09:30:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-q2-results-fy27-pat-926-crore\/"},"modified":"2026-11-04T15:00:18","modified_gmt":"2026-11-04T09:30:18","slug":"zydus-lifesciences-q2-results-fy27-pat-926-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-q2-results-fy27-pat-926-crore\/","title":{"rendered":"Zydus Lifesciences Q2 Results FY27: Revenue Up 29.17% to Rs 7,909.60 Cr, PAT Falls to Rs 925.50 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Zydus Lifesciences Q2 Results FY27 were declared on 4 November 2026, and the quarterly results show revenue of Rs 7,909.60 Cr against Rs 6,123.20 Cr a year earlier, a YoY growth of 29.17%. Net profit fell 26.6% to Rs 925.50 Cr from Rs 1,260.90 Cr in the same quarter last year. The figures cover the July to September 2026 quarter of FY27.<\/p>\n<\/div>\n

Zydus Lifesciences Ltd (ZYDUSLIFE) Q2 Results FY27 announced on 4 November 2026, covering the company’s financial performance for the July to September quarter. Revenue stood at Rs 7,909.60 Cr and PAT at Rs 925.50 Cr, so the Zydus Lifesciences Q2 Results FY27 story pairs a higher top line with a lower bottom line, a combination that makes the full set of numbers worth reading together rather than one headline at a time. The results date makes this one of the first filings of the season for the company.<\/p>\n

This Zydus Lifesciences Q2 Results results analysis looks at the Financial Highlights, the disclosed business factors, the FY27 outlook and the risks to watch. It opens with the Financial Highlights table, which lines up this quarter against the same quarter of last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n